How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?

<h4>Background</h4>Onchocerciasis (river-blindness) in Africa is targeted for elimination through mass drug administration (MDA) with ivermectin. Onchocerciasis may cause various types of skin and eye disease. Predicting the impact of MDA on onchocercal morbidity is useful for future pol...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natalie V S Vinkeles Melchers, Wilma A Stolk, Michele E Murdoch, Belén Pedrique, Marielle Kloek, Roel Bakker, Sake J de Vlas, Luc E Coffeng
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/67c3e503d2574b8d9810145e9f64d819
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:67c3e503d2574b8d9810145e9f64d819
record_format dspace
spelling oai:doaj.org-article:67c3e503d2574b8d9810145e9f64d8192021-11-25T06:33:08ZHow does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?1935-27271935-273510.1371/journal.pntd.0009489https://doaj.org/article/67c3e503d2574b8d9810145e9f64d8192021-06-01T00:00:00Zhttps://doi.org/10.1371/journal.pntd.0009489https://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>Onchocerciasis (river-blindness) in Africa is targeted for elimination through mass drug administration (MDA) with ivermectin. Onchocerciasis may cause various types of skin and eye disease. Predicting the impact of MDA on onchocercal morbidity is useful for future policy development. Here, we introduce a new disease module within the established ONCHOSIM model to predict trends over time in prevalence of onchocercal morbidity.<h4>Methods</h4>We developed novel generic model concepts for development of symptoms due to cumulative exposure to dead microfilariae, accommodating both reversible (acute) and irreversible (chronic) symptoms. The model was calibrated to reproduce pre-control age patterns and associations between prevalences of infection, eye disease, and various types of skin disease as observed in a large set of population-based studies. We then used the new disease module to predict the impact of MDA on morbidity prevalence over a 30-year time frame for various scenarios.<h4>Results</h4>ONCHOSIM reproduced observed age-patterns in disease and community-level associations between infection and disease reasonably well. For highly endemic settings with 30 years of annual MDA at 60% coverage, the model predicted a 70% to 89% reduction in prevalence of chronic morbidity. This relative decline was similar with higher MDA coverage and only somewhat higher for settings with lower pre-control endemicity. The decline in prevalence was lowest for mild depigmentation and visual impairment. The prevalence of acute clinical manifestations (severe itch, reactive skin disease) declined by 95% to 100% after 30 years of annual MDA, regardless of pre-control endemicity.<h4>Conclusion</h4>We present generic model concepts for predicting trends in acute and chronic symptoms due to history of exposure to parasitic worm infections, and apply this to onchocerciasis. Our predictions suggest that onchocercal morbidity, in particular chronic manifestations, will remain a public health concern in many epidemiological settings in Africa, even after 30 years of MDA.Natalie V S Vinkeles MelchersWilma A StolkMichele E MurdochBelén PedriqueMarielle KloekRoel BakkerSake J de VlasLuc E CoffengPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 15, Iss 6, p e0009489 (2021)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Natalie V S Vinkeles Melchers
Wilma A Stolk
Michele E Murdoch
Belén Pedrique
Marielle Kloek
Roel Bakker
Sake J de Vlas
Luc E Coffeng
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
description <h4>Background</h4>Onchocerciasis (river-blindness) in Africa is targeted for elimination through mass drug administration (MDA) with ivermectin. Onchocerciasis may cause various types of skin and eye disease. Predicting the impact of MDA on onchocercal morbidity is useful for future policy development. Here, we introduce a new disease module within the established ONCHOSIM model to predict trends over time in prevalence of onchocercal morbidity.<h4>Methods</h4>We developed novel generic model concepts for development of symptoms due to cumulative exposure to dead microfilariae, accommodating both reversible (acute) and irreversible (chronic) symptoms. The model was calibrated to reproduce pre-control age patterns and associations between prevalences of infection, eye disease, and various types of skin disease as observed in a large set of population-based studies. We then used the new disease module to predict the impact of MDA on morbidity prevalence over a 30-year time frame for various scenarios.<h4>Results</h4>ONCHOSIM reproduced observed age-patterns in disease and community-level associations between infection and disease reasonably well. For highly endemic settings with 30 years of annual MDA at 60% coverage, the model predicted a 70% to 89% reduction in prevalence of chronic morbidity. This relative decline was similar with higher MDA coverage and only somewhat higher for settings with lower pre-control endemicity. The decline in prevalence was lowest for mild depigmentation and visual impairment. The prevalence of acute clinical manifestations (severe itch, reactive skin disease) declined by 95% to 100% after 30 years of annual MDA, regardless of pre-control endemicity.<h4>Conclusion</h4>We present generic model concepts for predicting trends in acute and chronic symptoms due to history of exposure to parasitic worm infections, and apply this to onchocerciasis. Our predictions suggest that onchocercal morbidity, in particular chronic manifestations, will remain a public health concern in many epidemiological settings in Africa, even after 30 years of MDA.
format article
author Natalie V S Vinkeles Melchers
Wilma A Stolk
Michele E Murdoch
Belén Pedrique
Marielle Kloek
Roel Bakker
Sake J de Vlas
Luc E Coffeng
author_facet Natalie V S Vinkeles Melchers
Wilma A Stolk
Michele E Murdoch
Belén Pedrique
Marielle Kloek
Roel Bakker
Sake J de Vlas
Luc E Coffeng
author_sort Natalie V S Vinkeles Melchers
title How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
title_short How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
title_full How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
title_fullStr How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
title_full_unstemmed How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
title_sort how does onchocerciasis-related skin and eye disease in africa depend on cumulative exposure to infection and mass treatment?
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/67c3e503d2574b8d9810145e9f64d819
work_keys_str_mv AT natalievsvinkelesmelchers howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment
AT wilmaastolk howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment
AT micheleemurdoch howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment
AT belenpedrique howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment
AT mariellekloek howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment
AT roelbakker howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment
AT sakejdevlas howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment
AT lucecoffeng howdoesonchocerciasisrelatedskinandeyediseaseinafricadependoncumulativeexposuretoinfectionandmasstreatment
_version_ 1718413687691149312